You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart

Awaiting product image

Article: Multimodality treatment for high-risk prostate cancer: New perspectives

€3.03

SKU: product-article-10797 Category: General

Description
Reviews (0)

Description

Multimodality treatment for high-risk prostate cancer: New perspectives

Reviews

There are no reviews yet.

Be the first to review “Article: Multimodality treatment for high-risk prostate cancer: New perspectives”

You must be logged in to post a review.

Top